Glass Jacobson Investment Advisors llc Cuts Stock Position in CVS Health Corporation $CVS

Glass Jacobson Investment Advisors llc decreased its position in shares of CVS Health Corporation (NYSE:CVS) by 22.1% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 836 shares of the pharmacy operator’s stock after selling 237 shares during the period. Glass Jacobson Investment Advisors llc’s holdings in CVS Health were worth $58,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of CVS. Avion Wealth lifted its holdings in shares of CVS Health by 99.0% during the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new position in CVS Health during the 2nd quarter valued at about $30,000. Bell Investment Advisors Inc raised its stake in CVS Health by 119.8% in the first quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after buying an additional 248 shares during the last quarter. Roxbury Financial LLC boosted its holdings in CVS Health by 78.3% in the second quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 202 shares in the last quarter. Finally, ORG Partners LLC grew its stake in shares of CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after acquiring an additional 377 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent analyst reports. UBS Group lifted their target price on shares of CVS Health from $79.00 to $96.00 and gave the stock a “buy” rating in a research note on Friday. Mizuho boosted their price objective on shares of CVS Health from $76.00 to $88.00 and gave the company an “outperform” rating in a report on Thursday, October 9th. Cowen reissued a “buy” rating on shares of CVS Health in a research report on Monday, August 4th. Leerink Partners lifted their price target on CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, October 16th. Finally, Morgan Stanley increased their price objective on CVS Health from $82.00 to $89.00 and gave the company an “overweight” rating in a report on Tuesday, October 14th. Two research analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $83.38.

Insider Buying and Selling at CVS Health

In other news, Director Anne A. Finucane sold 7,500 shares of the stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the sale, the director directly owned 22,156 shares of the company’s stock, valued at $1,573,519.12. This represents a 25.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Company insiders own 1.22% of the company’s stock.

CVS Health Stock Up 1.1%

Shares of CVS opened at $81.95 on Friday. The company has a market capitalization of $103.94 billion, a price-to-earnings ratio of 22.89, a PEG ratio of 0.90 and a beta of 0.60. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $83.52. The stock’s 50-day moving average price is $75.57 and its 200-day moving average price is $68.68. The company has a quick ratio of 0.62, a current ratio of 0.80 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.CVS Health’s revenue for the quarter was up 8.4% on a year-over-year basis. During the same period in the previous year, the company posted $1.83 earnings per share. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, October 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 3.2%. CVS Health’s payout ratio is presently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.